This article discusses the prevalence and clinical significance of antiphospholipid antibodies (aPL) in the normal, healthy pregnant population. Although an increased risk for adverse fetal outcome has been shown in a small subset of this population, most pregnancies in aPL-positive mothers have successful outcomes. We review the variations in aPL levels during pregnancy and consider screening strategies and therapeutic interventions in healthy aPL-positive pregnant women.